$3.79
0.112.99%
Last update: Oct 20, 5:48 PM
Adial Pharmaceuticals Inc (ADIL) Stock Price, Quote, News & History
ADILNASDAQ
Adial Pharmaceuticals completes AD04 demo batch, validating process transfer and enabling Phase 3 production and FDA IND updates.
You can purchase shares of Adial Pharmaceuticals (NASDAQ:ADIL) through any online brokerage.
Other companies in Adial Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Adial Pharmaceuticals has a consensus price target of $18.17.
The stock price for Adial Pharmaceuticals (NASDAQ: ADIL) is $3.79 last updated October 20, 2026 at 5:48 PM EDT.
There are no upcoming dividends for Adial Pharmaceuticals.
Adial Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Adial Pharmaceuticals.
Adial Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as...
